Related Experiment Video
Updated: Dec 7, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Pediatric patients with orofacial granulomatosis likely to subsequently develop intestinal Crohn's disease: Brief
Kristen L Chen1, Daren A Diiorio2, Yvonne E Chiu3
1School of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Insights
Orofacial granulomatosis (OFG) may indicate underlying Crohn's disease. Many OFG patients later develop intestinal Crohn's, necessitating long-term gastroenterology monitoring for early diagnosis.
Area of Science:
- Pediatric Gastroenterology
- Dermatology
- Immunology
Background:
- Orofacial granulomatosis (OFG) is a rare chronic inflammatory condition affecting the face and lips.
- The relationship between OFG and Crohn's disease (CD) remains debated, with OFG potentially being a distinct entity or an oral manifestation of CD.
Purpose of the Study:
- To investigate the association between orofacial granulomatosis and the subsequent development of Crohn's disease in pediatric patients.
- To determine the diagnostic yield of monitoring OFG patients for intestinal CD.
Main Methods:
- Retrospective review of 7 pediatric patients diagnosed with OFG between 2000 and 2018.
- Longitudinal follow-up to identify subsequent diagnoses of Crohn's disease.
Main Results:
- Four out of seven OFG patients (57%) were diagnosed with Crohn's disease.
- The median time from OFG diagnosis to CD diagnosis was 3.1 years (range 0.4–6.9 years).
Conclusions:
- Orofacial granulomatosis may serve as an early indicator of underlying Crohn's disease in pediatric patients.
- Gastroenterology evaluation and sustained monitoring are crucial for early detection of intestinal Crohn's disease in individuals with OFG.
Abstract:
Orofacial granulomatosis (OFG) is an uncommon chronic granulomatous condition presenting as perioral inflammation in the absence of systemic disease. There is continued debate regarding whether OFG is a distinct clinical disorder or a manifestation of orofacial Crohn's disease. Our retrospective review identified 7 patients diagnosed with OFG between 2000 and 2018 at a tertiary pediatric hospital. Four of the 7 patients subsequently developed Crohn's disease with a median delay of 3.1 years (range 0.4-6.9 years). This indicates that gastroenterology evaluation with long-term monitoring for intestinal Crohn's disease is warranted.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

